Showing results (81-90 of 114) with videos related to
Sort By:
Pageof 12
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 27, 2013
Psychosocial interventions for bipolar disorder and coping style modification: similar clinical outcomes, similar mechanisms?Sagar V Parikh, Lisa D Hawke, Ari Zaretsky, et al.Trials|January 4, 2014
Comparing the feasibility, acceptability, clinical-, and cost-effectiveness of mental health e-screening to paper-based screening on the detection of depression, anxiety, and psychosocial risk in pregnant women: a study protocol of a randomized, parallel-group, superiority trialDawn Kingston, Sheila McDonald, Anne Biringer, et al.Brain Imaging and Behavior|June 29, 2026
Prediction modeling in transdiagnostic risk: results from the PROCAN studyMohammed K Shakeel, Zeyad Abouyoussef, Paul D Metzak, et al.International Journal of Bipolar Disorders|December 26, 2014
Prophylactic lithium treatment and cognitive performance in patients with a long history of bipolar illness: no simple answers in complex disease-treatment interplayAndrea Pfennig, Martin Alda, Trevor Young, et al.Journal of the Canadian Association of Gastroenterology|July 12, 2019
Patient Engagement and Multidisciplinary Involvement Has an Impact on Clinical Guideline Development and Decisions: A Comparison of Two Irritable Bowel Syndrome Guidelines Using the Same DataPaul Moayyedi, Megan Marsiglio, Christopher N Andrews, et al.Journal of Affective Disorders|December 26, 2016
A randomized, double-blind, placebo-controlled, crossover trial evaluating the effect of intranasal insulin on cognition and mood in individuals with treatment-resistant major depressive disorderDanielle S Cha, Michael W Best, Christopher R Bowie, et al.The Journal of Clinical Psychiatry|June 20, 2020
Symptom Dimension of Interest-Activity Indicates Need for Aripiprazole Augmentation of Escitalopram in Major Depressive Disorder: A CAN-BIND-1 ReportRudolf Uher, Benicio N Frey, Lena C Quilty, et al.CNS Spectrums|May 23, 2023
Pro-inflammatory markers are associated with response to sequential pharmacotherapy in major depressive disorder: a CAN-BIND-1 reportM Ishrat Husain, Jane A Foster, Brittany L Mason, et al.Bipolar Disorders|June 15, 2005
Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversiesLakshmi N Yatham, Sidney H Kennedy, Claire O'Donovan, et al.BMJ Open|October 22, 2020
IMAGINE Network's Mind And Gut Interactions Cohort (MAGIC) Study: a protocol for a prospective observational multicentre cohort study in inflammatory bowel disease and irritable bowel syndromePaul Moayyedi, Glenda MacQueen, Charles N Bernstein, et al.Pageof 12